Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Feder

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|March 8, 2019
Chemerin Isoforms and Activity in ObesityChrista Buechler, Susanne Feder, Elisabeth M Haberl, et al.
Anticancer Research|January 2, 2020
Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver TumorsSusanne Feder, Arne Kandulski, Doris Schacherer, et al.
International Journal of Molecular Sciences|October 2, 2020
Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell InflammationSusanne Feder, Astrid Bruckmann, Nichole McMullen, et al.
International Journal of Molecular Sciences|August 15, 2019
Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular CarcinomaSusanne Feder, Arne Kandulski, Doris Schacherer, et al.
Clinical and Experimental Medicine|February 21, 2020
Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patientsSusanne Feder, Elisabeth M Haberl, Marlen Spirk, et al.
Anticancer Research|May 2, 2018
Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and HepatocarcinogenesisElisabeth M Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, et al.
Lipids in Health and Disease|September 16, 2019
Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilitiesLisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, et al.
Experimental and Molecular Pathology|December 28, 2019
Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8<sup>+</sup> T-cells and galectin-3 in the liverLisa Rein-Fischboeck, Elisabeth M Haberl, Ganimete Bajraktari, et al.
Lipids in Health and Disease|January 19, 2021
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosisSusanne Feder, Reiner Wiest, Thomas S Weiss, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 24, 2018
Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet modelLisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|March 8, 2019
Chemerin Isoforms and Activity in ObesityChrista Buechler, Susanne Feder, Elisabeth M Haberl, et al.
Anticancer Research|January 2, 2020
Serum Adiponectin Levels Do Not Distinguish Primary from Metastatic Liver TumorsSusanne Feder, Arne Kandulski, Doris Schacherer, et al.
International Journal of Molecular Sciences|October 2, 2020
Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell InflammationSusanne Feder, Astrid Bruckmann, Nichole McMullen, et al.
International Journal of Molecular Sciences|August 15, 2019
Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular CarcinomaSusanne Feder, Arne Kandulski, Doris Schacherer, et al.
Clinical and Experimental Medicine|February 21, 2020
Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patientsSusanne Feder, Elisabeth M Haberl, Marlen Spirk, et al.
Anticancer Research|May 2, 2018
Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and HepatocarcinogenesisElisabeth M Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, et al.
Lipids in Health and Disease|September 16, 2019
Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilitiesLisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, et al.
Experimental and Molecular Pathology|December 28, 2019
Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8<sup>+</sup> T-cells and galectin-3 in the liverLisa Rein-Fischboeck, Elisabeth M Haberl, Ganimete Bajraktari, et al.
Lipids in Health and Disease|January 19, 2021
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosisSusanne Feder, Reiner Wiest, Thomas S Weiss, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 24, 2018
Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet modelLisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, et al.
Pageof 2